An Infectious cDNA Clone of SARS-CoV-2

Cited by (649)

Items 101–200 of 649

1. Multi-task contrastive learning for automatic CT and X-ray diagnosis of COVID-19
   Jinpeng Li, Gangming Zhao, Yaling Tao, Penghua Zhai, Hao Chen, Huiguang He, Ting Cai · 2021 · Pattern Recognition
2. Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2
   Hongjie Xia, Jing Zou, Chaitanya Kurhade, Hui Cai, Qi Yang, Mark W. Cutler, David Cooper, Alexander Muik, Kathrin Ute Jansen, Xuping Xie et al. · 2022 · Cell Host & Microbe
3. Application of Nanotechnology in the COVID-19 Pandemic
   Dongki Yang · 2021 · International Journal of Nanomedicine
4. Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19
   Hengrui Liu, Sho Iketani, Arie Zask, Nisha Khanizeman, Eva Bednářová, F. Forouhar, Brandon S. Fowler, Seo Jung Hong, Hiroshi Mohri, Manoj S. Nair et al. · 2022 · Nature Communications
5. SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung
   Nanda Kishore Routhu, Narayanaiah Cheedarla, Venkata Satish Bollimpelli, Sailaja Gangadhara, Venkata Viswanadh Edara, Lilin Lai, Anusmita Sahoo, Ayalnesh Shiferaw, Tiffany M. Styles, Katharine A. Floyd et al. · 2021 · Nature Communications
6. A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs
   Nanda Kishore Routhu, Narayanaiah Cheedarla, Sailaja Gangadhara, Venkata Satish Bollimpelli, Arun Kumar Boddapati, Ayalnesh Shiferaw, Sheikh Abdul Rahman, Anusmita Sahoo, Venkata Viswanadh Edara, Lilin Lai et al. · 2021 · Immunity
7. A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions
   Yang Liu, Xianwen Zhang, Jianying Liu, Hongjie Xia, Jing Zou, Antonio E. Muruato, Sivakumar Periasamy, Chaitanya Kurhade, Jessica A. Plante, Nathen E. Bopp et al. · 2022 · Nature Communications
8. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection
   Martina Severa, Roberta A. Diotti, Marilena Paola Etna, Fabiana Rizzo, Stefano Fiore, Daniela Ricci, Marco Iannetta, Alessandro Sinigaglia, Alessandra Lodi, Nicasio Mancini et al. · 2021 · PLoS Pathogens
9. Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective
   Mona Seifert, Subhas Chandra Bera, Pauline van Nies, Robert N. Kirchdoerfer, Ashleigh Shannon, Thi-Tuyet-Nhung Le, Xiangzhi Meng, Hongjie Xia, James M. Wood, Lawrence D. Harris et al. · 2021 · eLife
10. Parsing the role of NSP1 in SARS-CoV-2 infection
    Tal Fisher, Avi Gluck, Krishna Narayanan, Makoto Kuroda, Aharon Nachshon, Jason C. Hsu, Peter Halfmann, Yfat Yahalom-Ronen, Hadas Tamir, Yaara Finkel et al. · 2022 · Cell Reports
11. Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain
    Victor K. Outlaw, Francesca T. Bovier, Megan C. Mears, Maria N.B. Cajimat, Yun Zhu, Michelle J. Lin, Amin Addetia, Nicole A. P. Lieberman, Vikas Peddu, Xuping Xie et al. · 2020 · mBio
12. Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
    Antonio E. Muruato, Michelle N. Vu, Bryan A. Johnson, Meredith E. Davis-Gardner, Abigail Vanderheiden, Kumari G. Lokugamage, Craig Schindewolf, Patricia A. Crocquet-Valdes, Rose M. Langsjoen, Jessica A. Plante et al. · 2021 · PLoS Biology
13. Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine
    Chaitanya Kurhade, Jing Zou, Hongjie Xia, Hui Cai, Qi Yang, Mark W. Cutler, David Cooper, Alexander Muik, Kathrin Ute Jansen, Xuping Xie et al. · 2022 · Nature Communications
14. A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence
    Xianwen Zhang, Yang Liu, Jianying Liu, Adam L. Bailey, Kenneth S. Plante, Jessica A. Plante, Jing Zou, Hongjie Xia, Nathen E. Bopp, Patricia V. Aguilar et al. · 2021 · Cell
15. Sarbecovirus ORF6 proteins hamper induction of interferon signaling
    Izumi Kimura, Yoriyuki Konno, Keiya Uriu, Kristina Hopfensperger, Daniel Sauter, So Nakagawa, Kei Sato · 2021 · Cell Reports
16. A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates
    María Pino, Talha Abid, Susan Pereira Ribeiro, Venkata Viswanadh Edara, Katharine A. Floyd, Justin C. Smith, Muhammad Bilal Latif, Gabriela Pacheco Sánchez, Debashis Dutta, Shelly Wang et al. · 2021 · Science Immunology
17. Variant analysis of 1,040 SARS-CoV-2 genomes
    Eric Christian Rouchka, Julia H. Chariker, Donghoon Chung · 2020 · PLoS ONE
18. SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression
    Artem A. Nemudryi, Anna Nemudraia, Tanner Wiegand, Joseph E. Nichols, Deann Teresa Snyder, Jodi F. Hedges, Calvin Cicha, Helen Lee, Karl K. Vanderwood, Diane Bimczok et al. · 2021 · Cell Reports
19. Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication
    Yaqi Yu, Zhenzhou Wan, Jian‐Hua Wang, Xianguang Yang, Chiyu Zhang · 2022 · Virulence
20. Cold sensitivity of the SARS-CoV-2 spike ectodomain
    Robert J. Edwards, Katayoun Mansouri, Victoria Stalls, Kartik Manne, Brian E. Watts, Robert Parks, Katarzyna Janowska, S. Gobeil, Megan Kopp, Dapeng Li et al. · 2021 · Nature Structural & Molecular Biology
21. Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants
    Jared Pitts, Jiani Li, Jason K. Perry, Venice Du Pont, Nicholas C. Riola, Lauren Rodriguez, Xianghan Lu, Chaitanya Kurhade, Xuping Xie, Grégory Camus et al. · 2022 · Antimicrobial Agents and Chemotherapy
22. The human disease gene LYSET is essential for lysosomal enzyme transport and viral infection
    Christopher M. Richards, Sabrina Jabs, Wenjie Qiao, Lauren Varanese, Michaela Schweizer, Peter Mosen, Nicholas McIlvain Riley, Malte Klüssendorf, James R. Zengel, Ryan A. Flynn et al. · 2022 · Science
23. An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2
    Takuya Tada, Chen Fan, Jennifer Chen, Ramanjit Kaur, Kenneth A. Stapleford, Harry B. Gristick, Belinda M. Dcosta, Craig B. Wilen, Crina M. Nimigean, Nathaniel Roy Landau · 2020 · Cell Reports
24. Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies
    Qi Xiang, Linhao Li, Jie Wu, Miao Tian, Yang Fu · 2022 · Microbiological Research
25. SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release
    Junqueira, Caroline, Crespo, Ângela, Ranjbar, Shahin, Ingber, Jacob, Parry, Blair, Ravid, Sagi, Lacerda, Luna B. de, Lewandrowski, Mercedes, Clark, Sarah, Ho, Felicia et al. · 2021
26. Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein
    Alexander J. McAuley, Michael J. Kuiper, Peter A. Durr, Matthew P. Bruce, Jennifer A. Barr, Shawn Todd, Gough G. Au, Kim R. Blasdell, Mary Tachedjian, Sue Lowther et al. · 2020 · npj Vaccines
27. Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry
    Chuan Xu, Annie Wang, Mariana Marin, William J. Honnen, Santhamani Ramasamy, Edith Martin Porter, Selvakumar Subbian, Abraham Pinter, Gregory B. Melikyan, Wuyuan Lu et al. · 2021 · Viruses
28. Generation and Characterization of Recombinant SARS-CoV-2 Expressing Reporter Genes
    Kevin Chiem, Desarey Morales Vasquez, Jun‐Gyu Park, Roy N. Platt, Tim Anderson, Mark R. Walter, James J. Kobie, Chengjin Ye, Luis Martínez‐Sobrido · 2021 · Journal of Virology
29. Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktail
    Dong, Jinhui, Zost, Seth J., Greaney, Allison J., Starr, Tyler N., Dingens, Adam S., Chen, Elaine C., Chen, Rita E., Case, James Brett, Sutton, Rachel E., Gilchuk, Pavlo et al. · 2021
30. Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates
    Amin Addetia, Hong Jian Xie, Pavitra Roychoudhury, Lasata Shrestha, Michelle A. Loprieno, Meei-Li W. Huang, Keith R. Jerome, Alexander L. Greninger · 2020 · Journal of Clinical Virology
31. SARS-CoV-2 Infection of Airway Epithelial Cells
    Gwanghui Ryu, Hyun‐Woo Shin · 2021 · Immune Network
32. Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern
    Nariman Shahhosseini, George Giorgi Babuadze, Gary Wong, Gary Kobinger · 2021 · Microorganisms
33. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates
    Joseph R. Francica, Barbara J. Flynn, Kathryn E. Foulds, Amy T. Noe, Anne P. Werner, Ian N. Moore, Matthew Gagné, Timothy S. Johnston, Courtney Tucker, Rachel L. Davis et al. · 2021 · Science Translational Medicine
34. CCR2 Signaling Restricts SARS-CoV-2 Infection
    Abigail Vanderheiden, Jeronay Thomas, Allison L. Soung, Meredith E. Davis-Gardner, Katharine A. Floyd, Fengzhi Jin, David A. Cowan, Kathryn Pellegrini, Adrian Creanga, Amarendra Pegu et al. · 2021 · mBio
35. A proteome-scale map of the SARS-CoV-2–human contactome
    Dae‐Kyum Kim, Benjamin Weller, Chung‐Wen Lin, Dayag Sheykhkarimli, Jennifer J. Knapp, Guillaume Dugied, Andreas Zanzoni, Carles Pons, Marie J. Tofaute, Sibusiso B. Maseko et al. · 2022 · Nature Biotechnology
36. Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds
    Philip L. Tzou, Kaiming Tao, Janin Nouhin, Soo‐Yon Rhee, Benjamin D Hu, Shruti Pai, Neil T. Parkin, Robert W. Shafer · 2020 · Viruses
37. CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses
    Sallieu Jalloh, Judith Olejnik, Jacob L. Berrigan, Annuurun Nisa, Ellen L. Suder, Hisashi Akiyama, Maohua Lei, Sita Ramaswamy, Sanjay Tyagi, Yuri Bushkin et al. · 2022 · PLoS Pathogens
38. Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6
    Taha Y. Taha, Irene P. Chen, Jennifer M. Hayashi, Takako Tabata, Keith Walcott, Gabriella R. Kimmerly, Abdullah M. Syed, Alison Ciling, Rahul K. Suryawanshi, Hannah S. Martin et al. · 2023 · Nature Communications
39. Differential Effects of Antiseptic Mouth Rinses on SARS-CoV-2 Infectivity In Vitro
    Chuan Xu, Annie Wang, E. Hoskin, Carla Cugini, K. Markowitz, Theresa L. Chang, D. Fine · 2021 · Pathogens
40. Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes
    Andrea Lombardi, Elena Trombetta, Alessandra Cattaneo, Valeria Castelli, Emanuele Palomba, Mario Tirone, Davide Mangioni, Giuseppe Lamorte, Maria Manunta, Daniele Prati et al. · 2020 · Frontiers in Immunology
41. Detection of SARS-CoV-2 RNA Using a DNA Aptamer Mimic of Green Fluorescent Protein
    Bria S. VarnBuhler, Jared D. Moon, Sourav Kumar Dey, Jiahui Wu, Samie R. Jaffrey · 2022 · ACS Chemical Biology
42. Durability of immune responses to the BNT162b2 mRNA vaccine
    Mehul S. Suthar, Prabhu S. Arunachalam, Mengyun Hu, Noah Reis, Meera Trisal, Olivia Raeber, R. Sharon Chinthrajah, Meredith E. Davis-Gardner, Kelly E. Manning, Prakriti Mudvari et al. · 2022 · Med
43. Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2
    Manon Venet, Margarida Sá Ribeiro, Élodie Décembre, Alicia Bellomo, Garima Joshi, Célia Nuovo, Marine Villard, David Cluet, Magali Perret, Rémi Pescamona et al. · 2023 · Nature Communications
44. Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infection
    Jin Wei, Mia Madel Alfajaro, Ruth E. Hanna, Peter C. DeWeirdt, Madison S. Strine, William J. Lu-Culligan, Shang‐Min Zhang, Vincent R. Graziano, Cameron O. Schmitz, Jennifer Chen et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
45. The RNA Architecture of the SARS-CoV-2 3′-Untranslated Region
    Junxing Zhao, Jianming Qiu, Sadikshya Aryal, Jennifer L. Hackett, Jingxin Wang · 2020 · Viruses
46. A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual
    Francesca Caccuri, Alberto Zani, Serena Messali, Marta Giovanetti, Antonella Bugatti, Giovanni Campisi, Federica Filippini, Erika Scaltriti, Massimo Ciccozzi, Simona Fiorentini et al. · 2020 · Journal of Translational Medicine
47. Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection
    Marion Ferren, Valérie Favède, Didier Décimo, Mathieu Iampietro, Nicole A. P. Lieberman, Jean‐Luc Weickert, Rodolphe Pélissier, Magalie Mazelier, Olivier Terrier, Anne Moscona et al. · 2021 · Nature Communications
48. Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity
    Zemin Yang, Bryan A. Johnson, Victoria Meliopoulos, Xiaohui Ju, Peipei Zhang, Michael P. Hughes, Jinjun Wu, Kaitlin P. Koreski, Jemma E. Clary, Ti‐Cheng Chang et al. · 2024 · Cell Reports
49. Structure and inhibition of SARS-CoV-2 spike refolding in membranes
    Michael W. Grunst, Zhuan Qin, Esteban Dodero‐Rojas, Shilei Ding, Jérémie Prévost, Yaozong Chen, Yanping Hu, Marzena Pazgier, Shenping Wu, Xuping Xie et al. · 2024 · Science
50. Viral infection neutralization tests: A focus on severe acute respiratory syndrome‐coronavirus‐2 with implications for convalescent plasma therapy
    Daniele Focosi, Fabrizio Maggi, Paola Mazzetti, Mauro Pistello · 2020 · Reviews in Medical Virology
51. A rapid review of recent advances in diagnosis, treatment and vaccination for COVID-19
    Srikanth Umakanthan, Vijay Kumar Chattu, Anu Vinod Ranade, Debasmita Das, Abhishekh Basavarajegowda, Maryann Margaret Bukelo · 2021 · AIMS Public Health
52. Extracellular Vesicle Capture by AnTibody of CHoice and Enzymatic Release (EV‐CATCHER): A customizable purification assay designed for small‐RNA biomarker identification and evaluation of circulating small‐EVs
    Megan I. Mitchell, Iddo Z. Ben‐Dov, Christina Liu, Kenny Q. Ye, Kar Fai Chow, Yael G. Kramer, Anju Gangadharan, Steven Park, Sean Fitzgerald, Andrew Ramnauth et al. · 2021 · Journal of Extracellular Vesicles
53. Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2
    Maximilian Große, Natalia Ruétalo, Mirjam Layer, Dan Hu, Ramona Businger, Sascha Rheber, Christian Setz, Pia Rauch, Janina Auth, Maria Fröba et al. · 2021 · Viruses
54. Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
    Yanping Hu, Jing Zou, Chaitanya Kurhade, Xiangxue Deng, Hope C. Chang, Debora K. Kim, Pei‐Yong Shi, Ping Ren, Xuping Xie · 2023 · Emerging Microbes & Infections
55. Challenges and recent progress in the governance of biosecurity risks in the era of synthetic biology
    Tao Sun, Jie Song, Meng Wang, Zhao Chao, Weiwen Zhang · 2022 · Journal of Biosafety and Biosecurity
56. Disparate temperature-dependent virus – host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium
    Philip V’kovski, Mitra L. Gultom, Jenna Nicole Kelly, Silvio Steiner, Julie Russeil, Bastien Mangeat, Elisa Cora, Joern Pezoldt, Melle Holwerda, Annika Kratzel et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
57. Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses
    Chengjin Ye, Kevin Chiem, Jun‐Gyu Park, Jesus A. Silvas, Desarey Morales Vasquez, Julien Sourimant, Michelle J. Lin, Alexander L. Greninger, Richard Karl Plemper, Jordi Bertran Torrelles et al. · 2021 · Proceedings of the National Academy of Sciences
58. A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants
    Ching‐Wen Chang, Krishna Mohan Parsi, Mohan Somasundaran, Emma Vanderleeden, John Cruz, Alyssa Cousineau, Ping Liu, Qi Li, Yang Wang, René Maehr et al. · 2022 · Viruses
59. Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines
    Li Wang, Markus H. Kainulainen, Nannan Jiang, Han Di, Gaston Bonenfant, Lisa A. Mills, Michael Currier, Punya Shrivastava-Ranjan, Brenda M. Calderon, Mili Sheth et al. · 2022 · Nature Communications
60. Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine
    Prabhu S. Arunachalam, Yupeng Feng, Usama Ashraf, Mengyun Hu, Alexandra C. Walls, Venkata Viswanadh Edara, Veronika I. Zarnitsyna, Pyone P. Aye, Nadia Golden, Marcos C. Miranda et al. · 2022 · Science Translational Medicine
61. A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2
    Yang Zhang, Wuhui Song, Shuiye Chen, Zhenghong Yuan, Zhigang Yi · 2020 · Antiviral Research
62. Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant
    Rajesh M. Valanparambil, Jennifer Wilkinson Carlisle, Susanne L. Linderman, Akil Akhtar, Ralph Linwood Millett, Lilin Lai, Andrés Chang, Ashley A. McCook‐Veal, Jeffrey M. Switchenko, Tahseen H. Nasti et al. · 2022 · Journal of Clinical Oncology
63. Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice
    Lilit Grigoryan, Audrey W. Q. Lee, Alexandra C. Walls, Lilin Lai, Benjamin D Franco, Prabhu S. Arunachalam, Yupeng Feng, Wei Luo, Abigail Vanderheiden, Katharine A. Floyd et al. · 2022 · npj Vaccines
64. Coronavirus (SARS-CoV-2) Pandemic: Future Challenges for Dental Practitioners
    Ioana Roxana Bordea, Edit Xhajanka, Sebastian Candrea, Simion Bran, Florin Gligor Onisor, Alessio Danilo Inchingolo, Giuseppina Malcangi, Van Hung Pham, Angelo Michele Inchingolo, Antônio Scarano et al. · 2020 · Microorganisms
65. The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice
    Irfan Ullah, Guillaume Beaudoin-Bussières, Kelly Symmes, Marc Cloutier, Éric Ducas, Alexandra Tauzin, Annemarie Laumaea, Michael W. Grunst, Katrina Dionne, Jonathan Richard et al. · 2022 · Cell Reports Medicine
66. Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen
    Alice Mac Kain, Ghizlane Maarifi, Sophie‐Marie Aicher, Nathalie Jane Arhel, Artem Baidaliuk, Sandie Munier, Flora Donati, Thomas Vallet, Quang Dinh Tran, Alexandra Hardy et al. · 2022 · Nature Communications
67. Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth
    Zhiqiang Ku, Xuping Xie, Jianqing Lin, Peng Gao, Bin Wu, Abbas El Sahili, Hang Su, Yang Liu, Xiaohua Ye, Eddie Yong Jun Tan et al. · 2022 · Nature Communications
68. SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3
    Craig Schindewolf, Kumari G. Lokugamage, Michelle N. Vu, Bryan A. Johnson, Dionna Scharton, Jessica A. Plante, Birte Kalveram, Patricia A. Crocquet-Valdes, Stephanea L. Sotcheff, Elizabeth A. Jaworski et al. · 2023 · Journal of Virology
69. ACE2-dependent and -independent SARS-CoV-2 entries dictate viral replication and inflammatory response during infection
    Tianhao Duan, Changsheng Xing, Junjun Chu, Xiangxue Deng, Yang Du, Xin Liu, Yuzhou Hu, Qian Chen, Bingnan Yin, Helen Y. Wang et al. · 2024 · Nature Cell Biology
70. A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection
    Nanda Kishore Routhu, Sailaja Gangadhara, Lilin Lai, Meredith E. Davis-Gardner, Katharine A. Floyd, Ayalnesh Shiferaw, Yannic C. Bartsch, Stephanie Fischinger, Georges Khoury, Sheikh Abdul Rahman et al. · 2022 · Science Immunology
71. Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2
    Douglas F. Lake, Alexa J. Roeder, Erin J. Kaleta, Paniz Jasbi, Kirsten Pfeffer, Calvin Koelbela, Sivakumar Periasamy, Natalia A. Kuzmina, Alexander A. Bukreyev, Thomas E. Grys et al. · 2021 · Journal of Clinical Virology
72. Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection
    Chaitanya Kurhade, Jing Zou, Hongjie Xia, Mingru Liu, Qi Yang, Mark W. Cutler, David Cooper, Alexander Muik, Uğur Şahin, Kathrin Ute Jansen et al. · 2022 · Emerging Microbes & Infections
73. Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies
    Hai Trong Nguyen, Darryl Falzarano, Volker Gerdts, Qiang Liu · 2021 · Journal of Virology
74. Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populations
    Helms, Louisa, Marchiano, Silvia, Stanaway, Ian B., Hsiang, Tien-Ying, Juliar, Benjamin A., Saini, Shally, Zhao, Yan Ting, Khanna, Akshita, Menon, Rajasree, Alakwaa, Fadhl et al. · 2021 · JCI Insight
75. SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis
    David A. Coil, Timothy E. Albertson, Shefali Banerjee, Greg Brennan, A.J. Campbell, Stuart H. Cohen, Satya Dandekar, Samuel L. Díaz‐Muñoz, Jonathan A. Eisen, Tracey Goldstein et al. · 2021 · PLoS ONE
76. Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination
    Alexandra Herrmann, Doris Jungnickl, Arne Cordsmeier, Antonia Sophia Peter, Klaus Überla, Armin Ensser · 2021 · International Journal of Molecular Sciences
77. Betacoronavirus Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic
    Alejandro Llanes, Carlos Mario Restrepo, Zuleima Caballero E., Sreekumari Rajeev, Melissa A. Kennedy, Ricardo Lleonart · 2020 · International Journal of Molecular Sciences
78. Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2
    Mariana F. Tioni, Robert Jordan, Angie Silva Pena, Aditya Garg, Danlu Wu, Shannon I. Phan, Christopher M. Weiss, Xing Cheng, Jack J. Greenhouse, Tatyana Orekov et al. · 2022 · npj Vaccines
79. Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant
    Venkata Viswanadh Edara, Katharine A. Floyd, Lilin Lai, Meredith E. Davis-Gardner, William Hudson, Anne L Piantadosi, Jesse J. Waggoner, Ahmed Babiker, Rafi Ahmed, Xuping Xie et al. · 2021 · medRxiv
80. Functions of Coronavirus Accessory Proteins: Overview of the State of the Art
    Puxian Fang, Liurong Fang, Huichang Zhang, Sijin Xia, Shaobo Xiao · 2021 · Viruses
81. Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease
    Yuxi Lin, Ruochen Zang, Yanlong Ma, Zhuoya Wang, Li Li, Siyuan Ding, Rong Zhang, Zhiqiang Wei, Jinbo B. Yang, Xin Wang · 2021 · International Journal of Molecular Sciences
82. Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence
    Aarthi Talla, Suhas V. Vasaikar, Maria P. Lemos, Zoe Moodie, Mark-Phillip Pebworth, Kathy E. Henderson, Kristen W. Cohen, Julie Czartoski, Lilin Lai, Mehul S. Suthar et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
83. Identification of SARS-CoV-2 Spike Palmitoylation Inhibitors That Results in Release of Attenuated Virus with Reduced Infectivity
    Ahmed Ramadan, Karthick Mayilsamy, Andrew R. McGill, Anandita Ghosh, Marc A. Giulianotti, Haley M. Donow, Shyam S. Mohapatra, Subhra Mohapatra, Bala Chandran, Robert J. Deschenes et al. · 2022 · Viruses
84. QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis
    Michelle N. Vu, Kumari G. Lokugamage, Jessica A. Plante, Dionna Scharton, Aaron Oakley Bailey, Stephanea L. Sotcheff, Daniele M. Swetnam, Bryan A. Johnson, Craig Schindewolf, R. Elias Alvarado et al. · 2022 · Proceedings of the National Academy of Sciences
85. Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection
    Jiakai Hou, Yanjun Wei, Jing Zou, Roshni Jaffery, Long Sun, Shaoheng Liang, Ningbo Zheng, Ashley M. Guerrero, Nicholas A. Egan, Ritu Bohat et al. · 2024 · Nature Communications
86. A simple reverse genetics method to generate recombinant coronaviruses
    Julien Mélade, Géraldine Piorkowski, Franck Touret, Toscane Fourié, Jean‐Sélim Driouich, Maxime Cochin, Hawa Sophia Bouzidi, Bruno Coutard, Antoine Nougaırède, Xavier Nicolas de Lamballerie · 2022 · EMBO Reports
87. The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization
    Jing Zou, Xuping Xie, Camila R. Fontes-Garfias, Kena A. Swanson, Isis Kanevsky, Kristin R. Tompkins, Mark W. Cutler, David Cooper, Philip R. Dormitzer, Pei‐Yong Shi · 2021 · npj Vaccines
88. SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D
    Madeline J. Lee, Michelle W. Leong, Arjun Rustagi, A. Beck, Leiping Zeng, S. Holmes, L. Qi, C. Blish · 2022 · bioRxiv
89. Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2
    Hongjie Xia, Pei‐Yong Shi · 2020 · Journal of Interferon & Cytokine Research
90. Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infection
    Jin Wei, Ajinkya Patil, Clayton K. Collings, Mia Madel Alfajaro, Yu Liang, Wesley L. Cai, Madison S. Strine, Renata B. Filler, Peter C. DeWeirdt, Ruth E. Hanna et al. · 2023 · Nature Genetics
91. Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility
    Pei‐Yong Shi, Jessica A. Plante, Yang Liu, Jianying Liu, Hongjie Xia, Bryan A. Johnson, Kumari G. Lokugamage, Xianwen Zhang, Antonio E. Muruato, Jing Zou et al. · 2020 · bioRxiv
92. Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replication
    Jennifer Chen, Mia Madel Alfajaro, Jin Wei, Ryan Dz-Wei Chow, Renata B. Filler, Stephanie C. Eisenbarth, Craig B. Wilen · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
93. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve In Vitro to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage
    Nikita Shiliaev, Tetyana Lukash, Oksana Palchevska, David K. Crossman, Todd Jason Green, Michael R. Crowley, Elena I. Frolova, Ilya V. Frolov · 2021 · Journal of Virology
94. SARS-CoV-2 couples evasion of inflammatory response to activated nucleotide synthesis
    Chao Qin, Youliang Rao, Hao Yuan, Tingyu Wang, Jun Zhao, Bianca Espinosa, Yongzhen Liu, Shu Jie Zhang, Ali Can Savas, Qizhi Liu et al. · 2022 · Proceedings of the National Academy of Sciences
95. Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
    Matthew D. Hall, James Melvin Anderson, Annaliesa S. Anderson, David A. Baker, James E. Bradner, Kyle R. Brimacombe, Elizabeth A. Campbell, Kizzmekia S. Corbett, Kara L. Carter, Sara R. Cherry et al. · 2021 · The Journal of Infectious Diseases
96. Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19
    Alessandra Soares Schanoski, Natalie Sauerwald, Carl W. Goforth, Sivakumar Periasamy, Dawn L. Weir, Stephen E. Lizewski, Rhonda A. Lizewski, Yongchao Ge, Natalia A. Kuzmina, Venugopalan D. Nair et al. · 2022 · Frontiers in Immunology
97. AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans
    Lilit Grigoryan, Yupeng Feng, Lorenza Bellusci, Lilin Lai, Bushra Wali, Madison Leigh Ellis, Meng Yuan, Prabhu S. Arunachalam, Mengyun Hu, Sangeeta Kowli et al. · 2024 · Science Immunology
98. A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery
    Yunyun Jin, Hanwen Lin, Liu Cao, Wei-Chen Wu, Yanxi Ji, Liubing Du, Yiling Jiang, Yanchun Xie, Kuijie Tong, Fan Xing et al. · 2021 · Virologica Sinica
99. Broad-Spectrum In Vitro Antiviral Activity of ODBG-P-RVn: An Orally-Available, Lipid-Modified Monophosphate Prodrug of Remdesivir Parent Nucleoside (GS-441524)
    Michael K. Lo, Punya Shrivastava-Ranjan, Payel Chatterjee, Mike Flint, James R. Beadle, Nadejda Valiaeva, Joyce A. Murphy, Robert Turner Schooley, Karl Y. Hostetler, Joel M. Montgomery et al. · 2021 · Microbiology Spectrum
100. Vaccines platforms and COVID-19: what you need to know
     Isabel Acosta-Coley, Leonor Cervantes-Ceballos, Lesly Patricia Tejeda Benítez, Lucellys Sierra-Marquez, María Cabarcas-Montalvo, María Cecilia García Espiñeira, Wilfrido Coronell-Rodríguez, Bárbara Arroyo-Salgado · 2022 · Tropical Diseases Travel Medicine and Vaccines